Preventive effect of galectin-9 on double-stranded RNA-induced airway hyperresponsiveness in an exacerbation model of mite antigen-induced asthma in mice

Experimental Lung Research

Volumn 39, Issue 10, 2013, Pages 453-462

  Katoh, Shigeki ^a   Shimizu, Hiroki ^a   Obase, Yasushi ^a   Oomizu, Souichi ^b   Niki, Toshiro ^b   Ikeda, Masaki ^a   Mouri, Keiji ^a   Kobashi, Yoshihiro ^a   Hirashima, Mistuomi ^b   Oka, Mikio ^a  

^a KAWASAKI MEDICAL SCHOOL   (Japan)

^b KAGAWA UNIVERSITY   (Japan)

Author keywords

Asthma exacerbation; Double stranded RNA; Galectin 9; Mouse; Th1 cells

Indexed keywords

DOUBLE STRANDED RNA; ECALECTIN; GAMMA INTERFERON; POLYINOSINIC POLYCYTIDYLIC ACID; RANTES; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASTHMA; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE EXACERBATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; INFLAMMATORY CELL; LUNG ALVEOLUS MACROPHAGE; LUNG LAVAGE; MITE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; RESPIRATORY TRACT ALLERGY; RESPIRATORY TRACT INFLAMMATION;

ALLERGENS; ANIMALS; ANTIGENS, DERMATOPHAGOIDES; ASTHMA; BRONCHOALVEOLAR LAVAGE FLUID; CHEMOKINES; CYTOKINES; DISEASE MODELS, ANIMAL; FEMALE; GALECTINS; HUMANS; MACROPHAGES, ALVEOLAR; MICE; MICE, INBRED BALB C; POLY I-C; RECOMBINANT PROTEINS; RESPIRATORY HYPERSENSITIVITY;

EID: 84889817722     PISSN: 01902148     EISSN: 15210499     Source Type: Journal    
DOI: 10.3109/01902148.2013.850558     Document Type: Article

References (30)

1. Busse WW, Lemanske RF Jr: Asthma. N Engl J Med. 2001;344: 350-362.
2. Bousquet J, Mantzouranis E, Cruz AA, Aït-Khaled N, Baena- Cagnani CE, Bleecker ER, Brightling CE, Burney P, Bush A, Busse WW, Casale TB, Chan-Yeung M, Chen R, Chowdhury B, Chung KF, Dahl R, Drazen JM, Fabbri LM, Holgate ST, Kauffmann F, Haahtela T, Khaltaev N, Kiley JP, Masjedi MR, Mohammad Y, O'Byrne P, Partridge MR, Rabe KF, Togias A, van Weel C, Wenzel S, Zhong N, Zuberbier T: Uniform definition of asthma severity, control, and exacerbations: Document presented for the World Health Organization Consultation on Severe Asthma. J Allergy Clin Immunol. 2010;126: 926-938.
3. O'Byrne PM: Therapeutic strategies to reduce asthma exacerbations. J Allergy Clin Immunol. 2011;128: 257-263.
4. Johnston SL, Pttemore PK, Sanderson G: Community study of role of viral infections in exacerbation of asthma in 9-11 year old children. BMJ. 1995;310: 1225-1229.
5. Nicholson KG, Kent J, Ireland DC: Respiratory viruses and exacerbations of asthma in adults. BMJ. 1993;307: 982-986.
6. Jacobs BL, Langland JO: When two strands are better than one: the mediators and modulators of the cellular responses to double-stranded RNA. Virology. 1996;219: 339-349.
7. Steer SA,Moran JM,Maggi LB: Regulation of cyclooxygenase- 2 expression by macrophages in response to double-stranded RNA and viral infection. J Immunol. 2003;170: 1070-1076.
8. Hirashima M, Kashio Y, Nishi N, Yamauchi A, Imaizumi T, Kageshita T, Saita N, Nakamura T: Galectin-9 in physiological and pathological conditions. Glycoconj J. 2004;19: 593-600.
9. Zhu C, Anderson AC, Schubart A, Xiong H, Imitola J, Khoury SJ, Zheng XX, Strom TB, Kuchroo VK: The Tim-3 ligand galectin-9 negatively regulates T helper type 1 immunity. Nat Immunol. 2005;6: 1245-1252.
10. Yamamoto H, Kashio Y, Shoji H, Shinomaga R, Yoshimura T, Nishi N, Nabe T, Nakamura T, Kohno S, Hirashima M: Involvement of galectin-9 in guinea pig allergic airway inflammation. Int Arch Allergy Immunol. 2007;143(Suppl 1): 95-105.
11. Vega-Carrascal I, Reeves PE,McElvaney GN: The role of TIMcontaining molecules in airway disease and their potential as therapeutic targets. J Inflamm Res. 2012;5: 77-87.
12. Nishi N, Itoh A, Fujiyama A, Yoshida N, Araya S, Hirashima M, Shoji H, Nakamura T: Development of highly stable galectins: truncation of the linker peptide confers protease-resistance on tandem-repeat type galectins. FEBS Lett. 2005;579: 2058-2064.
13. Katoh S, IshiiN,Nobumoto A, TakeshitaK,Dai SY, Shinonaga R, Niki T, Nishi N, Tominaga A, Yamauchi A, Hirashima M: Galectin-9 inhibits CD44-hyluronan interaction and suppresses a murine model of allergic asthma. Am J Respir Crit Care Med. 2007;176: 27-35.
14. Katoh S, Kaminuma O, Hiroi T, Mori A, Ohtomo T,Maeda S, Shimizu H, Obase Y, Oka M: CD44 is critical for airway accumulation of antigen-specific Th2, but not Th1, cells induced by antigen challenge in mice. Eur J Immunol. 2011;41: 3198-3207.
15. Katoh S, Oomizu S, Niki T, Shimizu H, Obase Y, Korenaga M, Oka M, Hirashima M: Possible regulatory role of galectin-9 on Ascaris suum-induced eosinophilic lung inflammation in mice. Int Arch Allergy Immunol. 2012;158(Suppl 1): 58-65.
16. Lohning M, Stroehmann A, Coyle AJ, Grogan JL, Lin S, Gutierrez-Ramos JC, Levinson D, Radbruch A, Kamradt T: T1/ST2 is preferentially expressed on murine Th2 cells, independent of interleukin 4, interleukin 5, and interleukin 10, and important for Th2 effector function. Proc Natl Acad Sci USA. 1998;95: 6930-6935.
17. Jackson DJ, Johnston SL: The role of viruses in acute exacerbations of asthma. J Allergy Clin Immunol. 2010;125: 1178-1187.
18. Bosco A, Ehteshami S, Panyala S,Martinez FD: Interferon regulatory factor 7 is a major hub connecting interferon-mediated responses in virus-induced asthma exacerbations in vivo. J Allergy Clin Immunol. 2012;129: 88-94.
19. Kan-o K, Matsunaga Y, Fukuyama S, Moriwaki A, Hirai- Kitajima H, Yokomizo T, Aritake K, Urade Y, Nakanishi Y, Inoue H,Matsumoto K: Mast cells contribute to double-stranded RNA-induced augmentation of airway eosinophilia in a murine model of asthma. Respir Research. 2013;14:28.
20. Koya T, Takeda K, Kodama T, Miyahara N, Matsubara S, Balhorn A, Joetham A, Dakhama A, Gelfand EW: Rantes (CCL5) regulates airway responsiveness after repeated allergen challenge. Am J Respir Cell Mol Biol. 2006;35: 147-154.
21. Van Benten IJ, KleinJan A, Neijens HJ, Osterhaus AD, Fokkens WJ: Prolonged nasal eosinophilia in allergic patients after common cold. Allergy. 2001;56: 949-956.
22. Kumar RK, Yang M, Herbert C, Foster PS: Interferon-γ, pulmonary macrophages and airway responsiveness in asthma. Inflamm Allergy Drug Targets. 2012;11: 292-297.
23. Fryer AD, Jacoby DB: Parainfluenza virus infection damages inhibitory M2 muscarinic receptors on pulmonary parasympathetic nerves in the guinea-pig. Br J Pharmacol. 1991;102: 267-271.
24. Zang N, Xie X, Deng Y, Wu S, Wang L, Peng C, Li S, Ni K, Luo Y, Liu E: Resveratrol-mediated gamma interferon reduction prevents airway inflammation and airway hyperresponsiveness in respiratory syncytial virus-infected immunocompromised mice. J Virol. 2011;85: 13061-13068.
25. Nie Z, Nelson CS, Jacoby DB, Fryer AD: Expression and regulation of intercellular adhesion molecule-1 on airway parasympathetic nerves. J Allergy Clin Immunol. 2007;119: 1415-1422.
26. Nie Z, Jacoby DB, Fryer AD: Etanercept prevents airway hyperresponsiveness by protecting neuronal M2 muscarinic receptors in antigen-challenged guinea pigs. Br J Pharmacol. 2009;156: 201-210.
27. Nakayama M, Akiba H, Takeda K, Kojima Y, Hashiguchi M, Azuma M, Yagita H, Okumura K: Tim-3 mediates phagocytosis of apoptotic cells and cross-presentation. Blood. 2009;113: 3821-3830.
28. Ishikawa A, Imaizumi T, Yoshida H, Nishi N, Nakamura T, Hirashima M, Satoh K: Double-stranded RNA enhances the expression of galectin-9 in vascular endothelial cells. Immunol Cell Biol. 2004;82: 410-414.
29. Sly PD, Turner DJ, Collins RA, Hantos Z: Penh is not a validated technique for measuring airway function in mice. Am J Respir Crit Care Med. 2005;172:256.
30. Lundblad LKA: Issues determining direct airways hyperresponsiveness in mice. Front in Physiol. 2012;408.